All Posts

Diabetes-Management-Care-Market-Epidemiology-devices-therapies
Evolution in Diabetes Management

Diabetes, also known as diabetes mellitus, is one of the most serious and widespread public health concerns as it causes spikes in a patient's blood sugar levels to dangerously high levels. It is the most common type of endocrine disorder. The metabolic disorder can be classified into three main types, namely,...

Find More

competitive-intelligence-in-healthcare-sector
Competitive Intelligence: Stay Ahead of the Competitors in 2023!

Aiming to flourish in the pharmaceutical marketplace, it’s crucial to stay up to date with all the developments in one’s industry and every industry aspect that can affect one’s business. Furthermore, firms compete fiercely to keep their pipelines strong in the face of rapid innovation, changing patient needs, and ...

Find More

medtech-news-for-tectraum-vektor-medtronic-alcon-philips-sight-sciences
TecTraum’s pro2cool receives Breakthrough Device Designation; Vektor Obtains FDA Clearance for vMap; Medtronic’s TMVR system; Sight Sciences’s PRECISION Trial; Alcon to buy Ivantis; Philips to acquire Cardiologs

TecTraum’s pro2cool® receives FDA Breakthrough Device Designation for the Concussions treatment   On November 03, 2021, TecTraum Inc., working to develop the world’s first point-of-care treatment for concussions, announced that the US Food and Drug Administration (FDA) has provided a Breakthrough Device to its f...

Find More

weight-loss-obesity-market
An Insight Into the Weight Loss and Obesity Market

Obesity is one of the significant global health challenges, having a severe socio-economic impact.  It is basically an imbalance in calories consumed versus calories expended. Over the past two to three decades, it has grown to be a global epidemic and impacting people across age and geographic regions, which ...

Find More

pharma-happenings-for-alcon-philips-bioxcel-penumbra
Alcon to acquire Ivantis; Philips to takeover Cardiologs; Flunked cancer drug progresses in I-O in pancreatic cancer models; Indigo system CAT RX catheter meets primary endpoint in trial

Alcon to acquire Ivantis for USD 475 Million  Alcon announced that it intends to buy glaucoma surgery device maker Ivantis for USD 475 million upfront. Geneva, Switzerland-based Alcon aims to support its portfolio across cataract, refractive, retina and glaucoma offerings by taking over Ivantis and its n...

Find More

Gene-Therapy-for-Hemophilia
The Evolved Gene Therapy for Hemophilia

Hemophilia is an inherited rare disorder where blood doesn’t clot in the regular way because the person affected doesn’t make enough blood-clotting proteins (clotting factors). Without these factors, patients cannot stop bleeding when they are injured. Patients with more severe forms of the disease can experience s...

Find More

iga-nephropathy-treatment-market-size-share-trends-growth-cagr-companies-analysis
IgA Nephropathy – Navigating the Emerging Therapies and Key Companies in the Therapeutics Domain

IgA Nephropathy (IgAN), also called Berger’s disease, is an autoimmune rare disease affecting the kidneys. It impairs blood filtration in the kidneys' tiny blood channels. An aberrant protein destroys the filtering unit (glomerulus) inside the kidneys, causing IgA Nephropathy. It is estimated that 20–40% of persons...

Find More

medtech-news-updates-for-renew-bioscience-perimeter-medical-smithnephew-perimeter-medical-imaging-ai-saga-diagnostics-astrazeneca-magnus-medical-revalve-solutions
Smith+Nephew’s LEGION CONCELOC; Renew Bioscience’s Cerezen; Perimeter Medical’s ATLAS AI Project; SAGA Diagnostics-AZ’s Deal; Magnus Receives Breakthrough Device Designation; ReValve’s Transeptal Mitral Valve Replacement

ReValve Solutions, Inc. declares successful first human use of the Transeptal Mitral Valve Replacement  On November 01, 2021, ReValve Solutions, Inc., a company operating in the field of transcatheter structural heart replacement and repair, announced the successful first human use of its transcatheter, Palmetto...

Find More

Smart-Hospita-Market-Trends-and-Growth-Analysis
Smart Hospital: How it is Shaping the Future of Healthcare Delivery

The technological innovations over the past two to three decades have significantly changed the dynamics of various industries. Healthcare is no exception to it. From online appointments to robotic surgery and from telemedicine to digital payments, almost all the segments of healthcare delivery have immensely revol...

Find More

recent-pharma-biotech-news-for-prolacta-renovia-magnus-hinge-health
Magnus Medical’s tech gets breakthrough status; Prolacta develops tests for pathogens detection; Renovia gets breakthrough designation for leva system; Hinge Health secures $600M funding

Magnus Medical’s neurostimulation technology gets FDA breakthrough status to treat MDD Magnus Medical has secured a breakthrough device designation from the US Food and Drug Administration (FDA) for its neurostimulation technology for major depressive disorder (MDD) treatment. The individualised, rapid-acting...

Find More